What's The BUZZ?

Market News, Products, Services, and Trends

@MondayNightIBD OnDemand: Addressing the Cases That Challenge Your Practice

Gastroenterologists are trailblazers in health care social media, and #MondayNightIBD (#MNIBD) has harnessed that energy to establish gastroenterologists as not just social media influencers but as clinical practice influencers as well. #MNIBD is not just a weekly social media conversation – it is an international platform that is moving the field forward by crowdsourcing the expertise of leading inflammatory bowel disease (IBD) experts, community clinicians, and patients to meet the many challenges of IBD.


CME Outfitters is partnering with #MondayNightIBD to bring its founder Dr. Aline Charabaty’s hugely successful endeavor to a wider audience of learners via our virtual symposium. True to the social media format, a panel of experts will discuss a series of patient cases and integrate our live audience and Twitter polling with the goal of helping clinicians better understand, share, and implement optimal management strategies for IBD.


Learning Objectives

At the end of this CE activity, participants should be able to:

-Apply efficacy, safety, and comparative effectiveness data for existing and emerging therapies to optimize therapy selection for patients with IBD.

-Identify appropriate treatment strategies for special populations with IBD such as pregnant/lactating women, the elderly, and patients with Clostridioides difficile infection (CDI).

-Develop strategies, such as disease monitoring, therapeutic drug monitoring (TDM), shared decision-making (SDM), and patient education, to achieve optimal patient outcomes.


The following learning objectives pertain only to those requesting CNE or CPE credit:

-Explain efficacy, safety, and comparative effectiveness data for existing and emerging therapies to optimize therapy selection for patients with IBD.

-Identify appropriate treatment strategies for special populations with IBD such as pregnant/lactating women, the elderly, and patients with CDI.

-Describe strategies, such as disease monitoring, therapeutic drug monitoring (TDM), shared decision-making (SDM), and patient education, to achieve optimal patient outcomes.

10-rxinsider-staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

This post is related to:

SUBSCRIBE

Please enable JavaScript in your browser to complete this form.
Name
Subscription Choices
Checkboxes

Request information from @MondayNightIBD OnDemand: Addressing the Cases That Challenge Your Practice

Please enable JavaScript in your browser to complete this form.
Name
Address
Subscribe